Purchase Order W81K0021P0183
Award Date 10/1/21
Potential Completion Date 9/30/26
Potential Value $986K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Custer Hill, Fort Riley, KS, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ortho-Clinical Diagnostics Inc., a manufacturer of medical diagnostic equipment and reagents, has been awarded a $766,325.61 firm fixed price purchase order by the Defense Health Agency to provide chemistry testing services in Greece, New York through September 30, 2023. As the original equipment manufacturer and prime contractor, Ortho-Clinical Diagnostics will deliver the requested products and services without a set-aside designation or use of major subcontractors. This purchase order is...
- The Defense Health Agency awarded a purchase order valued at $106,717.41 to Ortho-Clinical Diagnostics, Inc. for ortho-clinical blood analyzer reagents and optical equipment, with a performance location at Fort Drum, New York. The contract, awarded on November 21, 2023, utilizes firm fixed price pricing and is structured as a standard purchase order with no set-aside designation. The ultimate completion date is November 20, 2028, providing a multi-year supply arrangement for critical...
- The Defense Health Agency awarded a definitive firm fixed-price contract to Ortho-Clinical Diagnostics, Inc. valued at $880,348.70 for clinical chemistry reagents and immunoassay reagents, with an ultimate completion date of January 20, 2030. The contract was awarded on January 21, 2025, without a set-aside designation, and will be performed at McGuire Air Force Base in New Jersey. Ortho-Clinical Diagnostics, a for-profit medical equipment manufacturer headquartered in Raritan, New Jersey,...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...
- Ortho-Clinical Diagnostics Inc. was awarded a $201,879.93 delivery order against the Critical Analyzers, Laboratory (FSS-66-III) schedule contract to provide various orthopedic-clinical diagnostics reagents to the Defense Health Agency. The delivery order has a completion date of September 30, 2024 and was awarded on October 1, 2021 under a firm fixed price contracting method. Performance will take place in Raritan, New Jersey. Ortho-Clinical Diagnostics Inc. is a medical equipment...
- Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer headquartered in Raritan, New Jersey, was awarded a firm fixed-price purchase order by the Medical Command (Defense) on October 1, 2019, for blood bank reagents and related supplies. The contract, which carries a ceiling value of $593,524.45 and was executed at Fort Stewart, Georgia, encompasses a base year and an option year 2 period, with an ultimate completion date of September 30, 2024. This award was issued...
- Ortho-Clinical Diagnostics Inc. was awarded a $1,878.12 delivery order against an indefinite-delivery contract held with the Defense Logistics Agency Troop Support Medical. The order is for RH-HR Control 15x10ml and will be fulfilled from the contractor's facility in Raritan, NJ by November 9, 2023. As a manufacturer of medical diagnostic equipment and reagents, Ortho-Clinical Diagnostics supports various federal healthcare programs through multiple blanket purchase agreements and indefinite...
- This is a purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and supplier, for the delivery of clinical chemistry reagents. The $312,063.80 firm fixed-price contract has an ultimate completion date of December 31, 2017. Ortho-Clinical Diagnostics is classified as a self-certified HUBZone joint venture, indicating the contract was not set aside for a specific business type. The company has received...
- The Department of the Army Medical Command awarded a $350,000.00 firm fixed-price delivery order contract to Ortho-Clinical Diagnostics Inc. for the provision of in vitro diagnostic reagents and test kits. The award was not set aside. Ortho-Clinical Diagnostics Inc. is a for-profit manufacturer of medical equipment and supplies, including advanced diagnostics to support patient care and treatment decisions. The company has a history of providing products and services to federal healthcare...
- This contract was awarded by the Department of the Army Medical Command to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer, on November 16, 2018. The $176,918.01 firm fixed price delivery order is for in vitro diagnostic reagents and test kits. No set-aside was used. Ortho-Clinical Diagnostics provides a range of diagnostic solutions, including blood bank analyzers, chemistry analyzers, reagents, and test kits, to federal agencies such as the Department of Veterans...